Search Results - "Kostikas, K"

Refine Results
  1. 1

    Omalizumab for the treatment of allergic rhinitis: a systematic review and meta-analysis by Tsabouri, S, Ntritsos, G, Koskeridis, F, Evangelou, E, Olsson, P, Kostikas, K

    Published in Rhinology (01-12-2021)
    “…Allergic rhinitis (AR), an IgE mediated inflammatory disease, significantly impacts quality of life of a considerable proportion of the general population…”
    Get full text
    Journal Article
  2. 2

    Clinical, functional and inflammatory characteristics in patients with paucigranulocytic stable asthma: Comparison with different sputum phenotypes by Ntontsi, P., Loukides, S., Bakakos, P., Kostikas, K., Papatheodorou, G., Papathanassiou, E., Hillas, G., Koulouris, N., Papiris, S., Papaioannou, A. I.

    Published in Allergy (Copenhagen) (01-11-2017)
    “…Background According to induced sputum cell count, four different asthma phenotypes have been recognized (eosinophilic, neutrophilic, mixed and…”
    Get full text
    Journal Article
  3. 3

    LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis by Rodrigo, Gustavo J, Price, David, Anzueto, Antonio, Singh, Dave, Altman, Pablo, Bader, Giovanni, Patalano, Francesco, Fogel, Robert, Kostikas, Konstantinos

    “…Randomized controlled trials (RCTs) indicate that long-acting bronchodilator combinations, such as β -agonist (LABA)/muscarinic antagonist (LAMA), have…”
    Get full text
    Journal Article
  4. 4

    Stratification of Patients with Chronic Obstructive Pulmonary Disease Using Volatile Organic Compounds by Exarchos, K P, Chronis, C, Lipirou, L, Sakkas, V, Kostikas, K

    “…Chronic obstructive pulmonary disease (COPD) is a common disease that causes long-term disability and death. Its natural history is punctuated by acute…”
    Get more information
    Journal Article
  5. 5

    Sputum and BAL Clara cell secretory protein and surfactant protein D levels in asthma by Emmanouil, P., Loukides, S., Kostikas, K., Papatheodorou, G., Papaporfyriou, A., Hillas, G., Vamvakaris, I., Triggidou, R., Katafigiotis, P., Kokkini, A., Papiris, S., Koulouris, N., Bakakos, P.

    Published in Allergy (Copenhagen) (01-06-2015)
    “…Clara cell secretory protein (CC16) is associated with Th2 modulation. Surfactant protein D (SPD) plays an important role in surfactant homeostasis and…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Patient-Reported Outcomes (PROs) in COPD Clinical Trials: Trends and Gaps by Afroz, Nuzhat, Gutzwiller, Florian S, Mackay, Alex J, Naujoks, Christel, Patalano, Francesco, Kostikas, Konstantinos

    “…Key characteristics of chronic obstructive pulmonary disease (COPD) that significantly affect health-related quality of life (HRQoL) include chest symptoms,…”
    Get full text
    Journal Article
  8. 8

    The asthma-COPD overlap syndrome: do we really need another syndrome in the already complex matrix of airway disease? by Kostikas, Konstantinos, Clemens, Andreas, Patalano, Francesco

    “…The term asthma-COPD overlap syndrome (ACOS) is one of multiple terms used to describe patients with characteristics of both COPD and asthma, representing ~20%…”
    Get full text
    Journal Article
  9. 9

    The Perception of Physicians on Gender-Specific Differences in the Diagnosis of COPD: Results from a Questionnaire-Based Survey by Raherison-Semjen, Chantal, Mezzi, Karen, Kostikas, Konstantinos, Mackay, Alexander J, Singh, Dave

    “…To evaluate the perception of physicians on gender-specific differences in the diagnosis of chronic obstructive pulmonary disease (COPD) using a qualitative…”
    Get full text
    Journal Article
  10. 10

    Dual bronchodilation vs triple therapy in the "real-life" COPD DACCORD study by Buhl, Roland, Criée, Carl-Peter, Kardos, Peter, Vogelmeier, Claus F, Kostikas, Konstantinos, Lossi, Nadine S, Worth, Heinrich

    “…No observational studies have evaluated the "real-world" effectiveness of dual bronchodilation comprising a long-acting β -agonist plus a long-acting…”
    Get full text
    Journal Article
  11. 11

    Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database by Kostikas, Konstantinos, Price, David, Gutzwiller, Florian S, Jones, Bethan, Loefroth, Emil, Clemens, Andreas, Fogel, Robert, Jones, Rupert, Cao, Hui

    “…Purpose: Previous studies have shown that opportunities to diagnose chronic obstructive pulmonary disease (COPD) early are often missed in primary care. This…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population by Vestbo, Jørgen, Vogelmeier, Claus F, Small, Mark, Siddall, James, Fogel, Robert, Kostikas, Konstantinos

    “…Blood eosinophils may predict response to inhaled corticosteroids (ICS) in chronic obstructive pulmonary disease (COPD) where ICS is recommended in patients at…”
    Get full text
    Journal Article
  15. 15

    Exhaled breath condensate in patients with asthma: implications for application in clinical practice by Kostikas, K., Koutsokera, A., Papiris, S., Gourgoulianis, K. I., Loukides, S.

    Published in Clinical and experimental allergy (01-04-2008)
    “…Summary Exhaled breath condensate (EBC) analysis, a rather appealing and promising method, can be used to evaluate conveniently and non‐invasively a wide range…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Sputum interleukin-13 as a biomarker for the evaluation of asthma control by Tsilogianni, Z., Hillas, G., Bakakos, P., Aggelakis, L., Konstantellou, E., Papaioannou, A. I., Papaporfyriou, A., Papiris, S., Koulouris, N., Loukides, S., Kostikas, K.

    Published in Clinical and experimental allergy (01-07-2016)
    “…Summary Background Asthma control refers to the extent to which the manifestations of asthma have been reduced or eradicated by treatment. Interleukin‐13…”
    Get full text
    Journal Article
  18. 18

    Increased levels of angiopoietins 1 and 2 in sputum supernatant in severe refractory asthma by Tseliou, E., Bakakos, P., Kostikas, K., Hillas, G., Mantzouranis, K., Emmanouil, P., Simoes, D., Alchanatis, M., Papiris, S., Loukides, S.

    Published in Allergy (Copenhagen) (01-03-2012)
    “…Background: Airway and vascular remodeling may play a prominent role in the clinical severity of severe refractory asthma (SRA). Angiopoietin‐1 (Ang‐1) is an…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Exhaled nitric oxide in asthma in adults: the end is the beginning? by Kostikas, K, Minas, M, Papaioannou, A I, Papiris, S, Dweik, R A

    Published in Current medicinal chemistry (01-04-2011)
    “…Approximately 20 years after the initial report of the measurement of exhaled nitric oxide (NO) in the exhaled air of humans, numerous publications have…”
    Get more information
    Journal Article